Document is current

Any future updates will be listed below

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

Crossref DOI link: https://doi.org/10.1007/s40123-019-0174-x

Published Online: 2019-03-13

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark